Yi Xin Tang (002727.SZ) released its performance for the first half of the year, with a net profit attributable to the parent company of 250 million yuan, a decrease of 11.44%.

Zhixun Finance and Economics APP reported that Yixin Pharmaceutical (002727.SZ) has released its semi-annual report for 2025. The company's operating income was 8.914 billion yuan, a decrease of 4.20% year-on-year. Net profit attributable to shareholders of the listed company was 250 million yuan, a decrease of 11.44% year-on-year. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 243 million yuan, a decrease of 18.41% year-on-year. Basic earnings per share were 0.4263 yuan. In addition, the company plans to distribute a cash dividend of 2 yuan (tax included) per 10 shares to all shareholders.